The glucagon receptor component increases energy expenditure and promotes fat breakdown (lipolysis), which may contribute to greater reductions in body weight compared with dual or single receptor agonists
Yeo and colleagues also reported an increase in the proportion of new users without FDA-approved indications, which rose from 0.21% to 0.37% between 2019 and 2023
Shop Medications , This experimental drug is currently only accessible through clinical trials, making it crucial to understand your options for safe and legal access
Impact of weight bias and stigma on quality of care and outcomes for patients with obesity
The MHRA has issued warnings about the risks of purchasing unlicensed injectable peptides online, noting that these products may be counterfeit, contaminated, or incorrectly labelled
Let us know if you notice significant redness, swelling, or pain